Image

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Recruiting
18 years and older
Male
Phase N/A

Powered by AI

Overview

In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportional presence of histological substructures in specific MRI volumes. Additional new MRI sequences that are not routinely recorded are required to calculate the microstructure models. In order to further investigate the possibilities of these new MRI sequences, this study will compare different mathematical models. In addition, a histopathological examination of the tissue will be performed.

Eligibility

Inclusion Criteria:

  • Humans with a prostate ≥18 years of age.
  • Patients with biopsy-proven PCa who are scheduled for an RPE.
  • Signed informed consent form (ICF) that demonstrates study participant understands the purpose of and procedures necessary for the study.
  • Willingness, ability, and legal capacity to participate in the study.
  • Ability to adhere to the prohibitions and restrictions defined in this protocol.

Exclusion Criteria:

  • Inability to give consent.
  • Prior hormone treatment (i.e., androgen deprivation treatment (ADT) and/or 5-ɑ-reductase inhibitors).
  • Prior PCa treatment.
  • Prior transurethral resection of the prostate (TUR-P) or other prostate surgery.
  • Prior total hip arthroplasty on one or both sides or other metal implants that interfere with the MRI acquisition of the hip region.
  • General contraindications for an MRI scan (i.e., pacemaker, relevant metal implants, etc.).

Study details
    Prostate Cancer

NCT07432360

Virdx, Inc.

15 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.